
Multiple Myeloma Treatment with Dendritic Cell Therapy
Multiple myeloma is a malignant blood disorder that affects plasma cells - white blood cells responsible for producing antibodies. This type of cancer typically develops in the bone marrow and can lead to bone damage, anemia, kidney failure, and a weakened immune system. Although it remains incurable, the last decade has brought significant progression in disease management.
According to the American Cancer Society, approximately 35,780 new cases of multiple myeloma are expected in the United States in 2024, with an estimated 12,540 deaths. While traditional therapies such as chemotherapy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.